Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2012
05/17/2012US20120122097 Compositions for use in identification of bacteria
05/17/2012US20120122096 Compositions for use in identification of bacteria
05/17/2012US20120122095 Materials and methods for the detection of anthrax related toxin genes
05/17/2012US20120122094 Composition and method for stabilizing fluorescent particles
05/17/2012US20120122093 Methods and kits for multiplex amplification of short tandem repeat loci
05/17/2012US20120122092 Compositions and methods for detecting Borrelia afzelii
05/17/2012US20120122091 Biological sampling device
05/17/2012US20120122090 Gene methylation in cancer diagnosis
05/17/2012US20120122089 Gene Marker For Evaluating Genetic Potential For Marbling In Bovine Individual And Method For Evaluating Genetic Potential For Marbling Using The Same
05/17/2012US20120122088 Methylation assay
05/17/2012US20120122087 5-Hydroxymethylcytosine as a biomarker for early detection, treatment and prognostic monitoring of cancer
05/17/2012US20120122086 Method for rapid detection and identification of bioagents in epidemiological and forensic investigations
05/17/2012US20120122085 Recql4/recql4 variant-p53 complex for altered mitochondrial function in rothmund-thomson syndrome
05/17/2012US20120122084 System for identifying and sorting living cells
05/17/2012US20120122083 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof
05/17/2012US20120122082 Method and kit for detection of microorganism
05/17/2012US20120122081 Differentiating picorna viruses, nucleic acids therefor, use thereof and bioassay methods employing them
05/17/2012US20120122080 Fluorescence energy transfer by competitive hybridization
05/17/2012US20120122079 Infection detection methods and systems and related compounds and compositions
05/17/2012US20120122077 Method to Detect and Sequence Post Translationally Modified Peptides
05/17/2012US20120122076 Purification of antibodies using simulated moving bed chromatography
05/17/2012US20120122073 Cis di-ahl modified controls for glycated hemoglobin s-a1c derived from healthy blood cells
05/17/2012US20120121706 PAR-1 Activation by Metalloproteinase-1 (MMP-1)
05/17/2012US20120121697 Compositions and Methods for the Diagnosis and Treatment of Inflammatory Disorders and Fibrotic Disease
05/17/2012US20120121639 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
05/17/2012US20120121633 Hiv cd4 binding site based covalent immunogen compositions
05/17/2012US20120121618 Predicting And Treating Prostate Cancer
05/17/2012US20120121610 Therapeutic agent and assay
05/17/2012US20120121608 Use of sam68 for modulating signaling through the tnf receptor
05/17/2012US20120121603 Compositions And Methods For The Therapy And Diagnosis Of Influenza
05/17/2012US20120121595 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
05/17/2012US20120121590 Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)
05/17/2012US20120121586 Modulators for her2 signaling in her2 expressing patients with gastric cancer
05/17/2012US20120121579 Treatment of oncostatin m receptor beta mediated heart failure
05/17/2012US20120121575 Prohibitin as target for cancer therapy
05/17/2012US20120121573 Treatment of Pulmonary Vascular Remodeling With Neprilysin
05/17/2012US20120121570 Test for Predicting Neutralization of Asparaginase Activity
05/17/2012US20120121568 Superoxide dismutase variants and methods of use thereof
05/17/2012US20120121559 Treatment and prevention of pathological conditions using iduna related techniques and compositions
05/17/2012US20120121554 Hmg-coa secondary metabolites and uses thereof
05/17/2012US20120121548 Production of reprogrammed pluripotent cells
05/17/2012US20120121515 Methods and compositions for cell-proliferation-related disorders
05/17/2012US20120121514 Needle array assembly and method for delivering therapeutic agents
05/17/2012US20120121511 Infection detection methods and systems and related compounds and compositions
05/17/2012US20120118308 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
05/17/2012US20120117867 Plants with Increased Yield
05/17/2012CA2770750A1 High yielding soybean variety xb26x12
05/17/2012CA2770726A1 High yielding soybean variety xb31n12
05/17/2012CA2770601A1 High yielding soybean variety xr29d12
05/17/2012CA2770599A1 High yielding soybean variety xb17q12
05/17/2012CA2770598A1 High yielding soybean variety xb29p12
05/17/2012CA2757585A1 Enhanced cleavage of von willebrand factor by adamts13
05/16/2012EP2453234A2 Methods for prognosing the ability of a zearalenone analog compound to treat cancer
05/16/2012EP2453024A2 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
05/16/2012EP2453023A2 Method for sequencing a polynucleotide template
05/16/2012EP2453022A1 Method for detection or analysis of target sequence in genomic dna
05/16/2012EP2453021A1 Novel indicator compounds
05/16/2012EP2453015A1 Identification marker responsive to interferon therapy for renal cell cancer
05/16/2012EP2452195A1 Methods of identifying a pair of binding partners
05/16/2012EP2451984A2 Detecting multinucleotide repeats
05/16/2012EP2451983A2 Compositions and methods for diagnosing and treating macular degeneration
05/16/2012EP2451982A2 Compositions and methods for mammalian genetics and uses thereof
05/16/2012EP2451981A1 Method for generating aptamers with improved off-rates
05/16/2012EP2451980A1 Chemically modified ligase cofactors, donors and acceptors
05/16/2012EP2451979A1 Human immunodeficiency virus type 1 (hiv-1) detection method and kit therefor
05/16/2012EP2451978A1 Screening method of therapeutic and diagnostic agents for tnf-alpha-induced diseases using reactive oxygen species modulator 1
05/16/2012EP2451977A1 Genetic markers associated with risk of diabetes mellitus
05/16/2012EP2451976A1 Nucleic acid nano-biosensors
05/16/2012EP2451975A1 Genetic variants contributing to risk of prostate cancer
05/16/2012EP2451974A2 Oligonucleotide-based compounds as inhibitors of toll-like receptors
05/16/2012EP2451973A1 Method for differentiation of polynucleotide strands
05/16/2012EP2451972A1 Methods of classifying biological samples for predicting response to tyrosine kinase inhibitor treatment
05/16/2012EP2451971A1 Diagnostic method and kit for the detection of a lymphocytic variant of hypereosinophilic syndrome
05/16/2012EP2451970A1 Methods for the diagnosis of multiple sclerosis based on its microrna expression profiling
05/16/2012EP2451969A2 Biomarkers for the early detection of autoimmune diseases
05/16/2012EP2451968A1 Highly sensitive rapid isothermal method for the detection of point mutations and snps, a set of primers and a kit therefor
05/16/2012EP2451967A1 Tivozanib response prediction
05/16/2012EP2451966A1 Methods for early detection of blood disorders
05/16/2012EP2451965A1 Bacterial adherence and anti-adherence to mucus, epithelial cells and other cells
05/16/2012EP2451951A1 Combined automated parallel synthesis of polynucleotide variants
05/16/2012EP2451947A1 Crystal structure of glyphosate acetyltransferase (glyat) and methods of use
05/16/2012EP2451834A1 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
05/16/2012EP2451269A1 Plant resistant to a pathogen
05/16/2012EP2268830B1 Peritoneal dialysis solution test method
05/16/2012EP2132335B1 Method for the detection of paratuberculosis
05/16/2012EP2104744B1 Compositions and methods for diagnosing, treating, and preventing prostate conditions
05/16/2012EP2053398B1 Method for confirming performance of optical detector and reference reagent used for same
05/16/2012EP2041271B1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
05/16/2012DE10235310B4 Verfahren zur Bestimmung allergener Potenz von Produkten Method for the determination of allergenic potency of products
05/16/2012DE102010060498A1 Isolierung und funktionale Identifizierung ganzer Zellen Isolation and functional identification of whole cells
05/16/2012CN202220175U Disposable electrochemical chip
05/16/2012CN1988970B Process for stimulating production of methane from petroleum in subterranean formations
05/16/2012CN1928119B Beta-lactamase SHV gene variation detecting chip and application thereof
05/16/2012CN1914334B Primer for detecting mycobacterium tuberculosis and kits
05/16/2012CN1839205B Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
05/16/2012CN1668763B 1L1RL-1 as a cardiovascular disease marker and therapeutic target
05/16/2012CN1575338B Bv8 nucleic acids and polypeptides with mitogenic activity
05/16/2012CN102460173A 组蛋白修饰用于癌症的临床诊断和预后 Histone modifications for clinical diagnosis and prognosis of cancer
05/16/2012CN102460153A 监控神经精神疾病治疗的生物标记 Monitoring of biomarkers for neuropsychiatric disease treatment
05/16/2012CN102459651A Method of determining response to treatment with immunomodulatory composition
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 3003